Landi, Lorenza
-
Vol 4, No 2 (April 30, 2012): Journal of Thoracic Disease - Research Highlight
Optimal front line treatment for European patients harboring EGFR mutations: Do longitude and race make a difference?
Abstract PDF Full Text -
Vol 9, No 8 (August 28, 2017): Journal of Thoracic Disease - Editorial
A few pills twice a day keep ALK-positive non-small-cell lung cancer at bay
Abstract PDF Full Text -
Vol 10, Supplement 17 (June 20, 2018): Journal of Thoracic Disease - Editorial
Cetuximab in the treatment of advanced non-small cell lung cancer: FISHing for a miraculous catch
Abstract PDF Full Text -
Vol 14, No 4 (April 27, 2022): Journal of Thoracic Disease - Editorial
Multidisciplinary and real life data: practical management of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC)
Details PDF Full Text COI Form